Health
CRO Acquisition Puts Clinical Trial Continuity Under Pressure
Curavit Clinical Research’s 2026 acquisition of Lindus Health assets raises practical questions for sponsors, sites and investigators about access, contracts, recruitment reach and the next operational checkpoint.
